Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis.

Gao Y, Mutter-Rottmayer E, Greenwalt AM, Goldfarb D, Yan F, Yang Y, Martinez-Chacin RC, Pearce KH, Tateishi S, Major MB, Vaziri C.

Nat Commun. 2016 Jul 5;7:12105. doi: 10.1038/ncomms12105.

2.

USP7 is essential for maintaining Rad18 stability and DNA damage tolerance.

Zlatanou A, Sabbioneda S, Miller ES, Greenwalt A, Aggathanggelou A, Maurice MM, Lehmann AR, Stankovic T, Reverdy C, Colland F, Vaziri C, Stewart GS.

Oncogene. 2016 Feb 25;35(8):965-76. doi: 10.1038/onc.2015.149. Epub 2015 May 11.

PMID:
25961918
3.

A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner.

Donohoe DR, Holley D, Collins LB, Montgomery SA, Whitmore AC, Hillhouse A, Curry KP, Renner SW, Greenwalt A, Ryan EP, Godfrey V, Heise MT, Threadgill DS, Han A, Swenberg JA, Threadgill DW, Bultman SJ.

Cancer Discov. 2014 Dec;4(12):1387-97. doi: 10.1158/2159-8290.CD-14-0501. Epub 2014 Sep 29.

4.

Cell cycle stage-specific roles of Rad18 in tolerance and repair of oxidative DNA damage.

Yang Y, Durando M, Smith-Roe SL, Sproul C, Greenwalt AM, Kaufmann W, Oh S, Hendrickson EA, Vaziri C.

Nucleic Acids Res. 2013 Feb 1;41(4):2296-312. doi: 10.1093/nar/gks1325. Epub 2013 Jan 7.

5.

Lack of a direct effect of 1,25-dihydroxycholecalciferol on parathyroid hormone secretion by normal bovine parathyroid glands.

Golden P, Greenwalt A, Martin K, Bellorin-Font E, Mazey R, Klahr S, Slatopolsky E.

Endocrinology. 1980 Aug;107(2):602-7.

PMID:
6893023
6.

Do vitamin D or its metabolites directly affect the release of PTH?

Golden P, Greenwalt A, Mazey R, Martin K, Slatopolsky E.

Contrib Nephrol. 1980;18:135-8. No abstract available.

PMID:
7353372
7.

A simplified technique for the measurement of intestinal absorption of calcium in the dog: effects of PO4 depletion and 25(OH)D3 in uremia.

Chanard JM, Rutherford WE, Greenwalt A, Coquis R, Slatopolsky E.

Calcif Tissue Int. 1980;30(3):199-203.

PMID:
6772287
8.
9.

Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog.

Rutherford WE, Bordier P, Marie P, Hruska K, Harter H, Greenwalt A, Blondin J, Haddad J, Bricker N, Slatopolsky E.

J Clin Invest. 1977 Aug;60(2):332-41.

10.

Chronic progressive renal disease: rate of change of serum creatinine concentration.

Rutherford WE, Blondin J, Miller JP, Greenwalt AS, Vavra JD.

Kidney Int. 1977 Jan;11(1):62-70.

11.

Selective uptake of intact parathyroid hormone by the liver: differences between hepatic and renal uptake.

Martin K, Hruska K, Greenwalt A, Klahr S, Slatopolsky E.

J Clin Invest. 1976 Oct;58(4):781-8.

12.

Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease.

Hruska KA, Kopelman R, Rutherford WE, Klahr S, Slatopolsky E, Greenwalt A, Bascom T, Markham J.

J Clin Invest. 1975 Jul;56(1):39-48.

13.

Parathyroid hormone (PTH) metabolism in chronic renal disease (CRD).

Hruska K, Kopelman R, Rutherford WE, Greenwalt A, Klahr S, Slatopolsky E.

Proc Eur Dial Transplant Assoc. 1975;11:457-64. No abstract available.

PMID:
1197270

Supplemental Content

Loading ...
Support Center